DocDollars

Lucid Diagnostics Inc.

NY · United States · Reporting entity ID 100000971892

Total reported 2019–2025
$2.93M
#892 of 2,960 reporting companies — 0% of all reported industry payments
$1.05M in general payments across 9,623 records, plus $1.87M in research funding across 231 records.

How it breaks down

General payments $1,054,313
Research funding $1,873,667

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Lucid Diagnostics Inc. reported $2.93M to US doctors and teaching hospitals from 2019 to 2025, ranking #892 of 2,960 reporting companies. 64% of that was research funding and 36% general payments such as consulting, speaking, food and travel. 9,623 general payment records and 231 research records were filed.

Common questions about Lucid Diagnostics Inc.

How much has Lucid Diagnostics Inc. paid US doctors?

Lucid Diagnostics Inc. reported $2,927,980 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $1,054,313 in general payments, $1,873,667 in research funding.

How does Lucid Diagnostics Inc. rank among drug and device companies?

It ranks #892 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Lucid Diagnostics Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.